TY - JOUR AU - Matsumoto, Toshihiko AU - Yamamura, Shogo AU - Nagai, Hiroki AU - Satake, Hironaga AU - Yasui, Hisateru PY - 2022 TI - Is modified FOLFIRINOX a standard regimen for 2nd line chemotherapy for pancreatic cancer after gemcitabine plus nab-paclitaxel failure?—insights from the MPACA-3 trial JF - Digestive Medicine Research; Vol 5 (June 30, 2022): Digestive Medicine Research Y2 - 2022 KW - N2 - UR - https://dmr.amegroups.org/article/view/8216